{"schema_version":"alpha-profile-public-v1","slug":"claude-nicaise","canonical_url":"https://registry.alpha.ac/people/claude-nicaise","as_of":"2026-09-22T08:03:29.134079+00:00","published_at":"2026-09-02T02:37:21.125862+00:00","last_reviewed_at":"2026-05-16T00:42:46.198+00:00","identity":{"display_name":"Claude Nicaise","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Chemomab Therapeutics Ltd.","company_slug":"chemomab-therapeutics-ltd","exchange":"NASDAQ","ticker":"CMMB","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm","effective_date":"2022-04-28","last_checked_at":"2026-04-29T00:04:01.902+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=claude-nicaise","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=claude-nicaise&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Physician with extensive U.S. and international experience in clinical drug development, regulatory strategy, and biotechnology. Owner/founder of Clinical Regulatory Services. Board member of Sarepta Therapeutics since 2015 and Mynoryx Therapeutics since 2017. Previously SVP at Alexion Pharmaceuticals and held senior roles at Bristol Myers Squibb. MD from Brussels University."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Chemomab Therapeutics Ltd.","organizationId":"chemomab-therapeutics-ltd","title":"Director","period":"2021-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Chemomab Therapeutics Ltd.","company_slug":"chemomab-therapeutics-ltd","exchange":"NASDAQ","ticker":"CMMB","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm","effective_date":"2022-04-28","last_checked_at":"2026-04-29T00:04:01.902+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Claude Nicaise as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:53:38.624888+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm","published_at":"2022-04-28T00:00:00+00:00","last_checked_at":"2026-05-15T22:53:38.52633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Claude Nicaise as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:42:46.422622+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001041/zk2329403.htm","published_at":"2023-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T00:42:46.28054+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Claude Nicaise currently serves as Director at Chemomab Therapeutics Ltd..","claim_state":"verified","valid_from":"2022-04-28","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:53:38.59176+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm","published_at":"2022-04-28T00:00:00+00:00","last_checked_at":"2026-05-15T22:53:38.52633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"Claude Nicaise serves on Audit.","claim_state":"verified","valid_from":"2022-04-28","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:53:38.608144+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm","published_at":"2022-04-28T00:00:00+00:00","last_checked_at":"2026-05-15T22:53:38.52633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Claude Nicaise as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:53:38.657408+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm","published_at":"2022-04-28T00:00:00+00:00","last_checked_at":"2026-05-15T22:53:38.52633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Claude Nicaise as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:42:46.455034+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001041/zk2329403.htm","published_at":"2023-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T00:42:46.28054+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Chemomab Therapeutics Ltd.","claim_text":"Claude Nicaise is associated with Chemomab Therapeutics Ltd..","claim_state":"verified","valid_from":"2023-03-20","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:42:46.402204+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001041/zk2329403.htm","published_at":"2023-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T00:42:46.28054+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Director","claim_text":"Claude Nicaise is listed as Director at Chemomab Therapeutics Ltd..","claim_state":"verified","valid_from":"2023-03-20","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:42:46.383377+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001041/zk2329403.htm","published_at":"2023-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T00:42:46.28054+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"other_company_role","claim_value":{"role":"Chairman of Compensation Committee","company":"Sarepta Therapeutics, Inc."},"claim_text":"Claude Nicaise is also linked to Sarepta Therapeutics, Inc. as Chairman of Compensation Committee.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.7,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:42:46.489376+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001041/zk2329403.htm","published_at":"2023-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T00:42:46.28054+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Claude Nicaise as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:53:38.641088+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm","published_at":"2022-04-28T00:00:00+00:00","last_checked_at":"2026-05-15T22:53:38.52633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Executive extraction classified technology background for Claude Nicaise as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:42:46.438811+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CMMB 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001041/zk2329403.htm","published_at":"2023-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T00:42:46.28054+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:claude-nicaise","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2021-01-01 · current","organization":"Chemomab Therapeutics Ltd.","organization_id":"chemomab-therapeutics-ltd"},"claim_text":"Director at Chemomab Therapeutics Ltd. (2021-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/claude-nicaise#profile","url":"https://registry.alpha.ac/people/claude-nicaise","dateModified":"2026-05-16T00:42:46.198+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/claude-nicaise#person","name":"Claude Nicaise","url":"https://registry.alpha.ac/people/claude-nicaise","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Chemomab Therapeutics Ltd.","tickerSymbol":"NASDAQ: CMMB"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","memberOf":{"@type":"Organization","name":"Chemomab Therapeutics Ltd.","url":"https://registry.alpha.ac/companies/chemomab-therapeutics-ltd","tickerSymbol":"NASDAQ: CMMB"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001678/zk2227688.htm","name":"CMMB DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001041/zk2329403.htm","name":"CMMB 10-K executive officers"}],"mainEntityOfPage":"https://registry.alpha.ac/people/claude-nicaise"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":7,"corroborated":3,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":10,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":7,"corroborated":3,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":10,"corroborated_claims":3,"sources":4,"distinct_sources":2,"role_claims":1,"last_reviewed_at":"2026-05-16T00:42:46.198+00:00","observed_at":"2026-09-22T08:03:29.134079+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"claude-nicaise","canonical_url":"https://registry.alpha.ac/people/claude-nicaise"},"publication":{"published_at":"2026-09-02T02:37:21.125862+00:00","last_reviewed_at":"2026-05-16T00:42:46.198+00:00","as_of":"2026-09-22T08:03:29.134079+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/claude-nicaise","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/claude-nicaise","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/claude-nicaise.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}